Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury

Cellular and Molecular Life Sciences

Volumn 61, Issue 6, 2004, Pages 657-668

  Arundine, M ^a   Tymianski, M ^a  

^a NONE

Author keywords

Calcium; Glutamate; Ischemia; Nitric oxide; NMDA receptor; Postsynaptic density protein 95; ROS; Superoxide; Traumatic brain injury

Indexed keywords

AMINO ACID; CALCIUM; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CENTRAL NERVOUS SYSTEM; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NONHUMAN; REVIEW; STROKE;

ANIMALS; BRAIN INJURIES; BRAIN ISCHEMIA; GLUTAMIC ACID; HUMANS; N-METHYLASPARTATE; NERVE DEGENERATION; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 1842558602     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3319-x     Document Type: Review

References (163)

1. Faden A. I., Demediuk P., Panter S. S. and Vink R. (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244: 798-800
2. Simon R. P., Swan J. H. and Meldrum B. S. (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850-852
3. Ozyurt E., Graham D. I., Woodruff G. N. and McCulloch J. (1988) Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J. Cereb. Blood Flow. Metab. 8: 138-143
4. Choi D. W. (1985) Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58: 293-297
5. Choi D. W. (1987) Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7: 369-379
6. Choi D. W. (1995) Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18: 58-60
7. Choi D. W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11: 465-467
8. Tymianski M. (1996) Cytosolic calcium concentrations and cell death in vitro. In: Advances in Neurology: Cellular and Molecular Mechanisms of Ischemic Brain Damage, Siesjo B. K. and Wieloch T. (eds), pp. 85-105, Lippincott-Raven, Philadelphia
9. Lucas D. R. and Newhouse J. P. (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol. 58: 193-201
10. Olney J. W. (1978) Neurotoxicity of excitatory amino acids. In: Kainic Acid as a Tool in Neurobiology, McGeer E. G., Olney J. W. and McGeer P. L. (eds), Raven Press, pp. 95-121, New York
11. Olney J. W. (1969) Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science 164: 719-721
12. Kass I. S. and Lipton P. (1982) Mechanisms involved in irreversible anoxic damage to the in vitro rat hippocampal slice. J. Physiol. 332: 459-472
13. Rothman S. M. (1983) Synaptic activity mediates death of hypoxic neurons. Science 220: 536-537
14. de Weille J. R., Schweitz H., Maes P., Tartar A. and Lazdunski M. (1991) Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc. Natl. Acad. Sci. USA 88: 2437-2440
15. Rothman S. M. (1985) The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J. Neurosci. 5: 1483-1489
16. Olney J. W., Price M. T., Samson L. and Labruyere J. (1986) The role of specific ions in glutamate neurotoxicity. Neurosci. Lett. 65: 65-71
17. Berdichevsky E., Riveros N., Sanches-Armass S. and Orrego F. (1983) Kainate, N-methylaspartate and other excitatory amino acids increase calcium influx onto rat brain cortex cells in vitro. Neurosci. Lett. 36: 75-80
18. Choi D. W. (1987) Maulucci-Gedde M, Kriegstein A. R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7: 357-368
19. Tymianski M. and Tator C. H. (1996) Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38: 1176-1195
20. Hossmann K. A. (1994) Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised. Brain Pathol. 4: 23-36
21. Siesjo B. K., Zhao Q., Pahlmark K., Siesjo P., Katsura K., Folbergrova J. (1995) Glutamate, calcium and free radicals as mediators of ischemic brain damage. Ann. Thorac. Surg. 59: 1316-1320
22. 2+ blockade of NMDA current in mechanically injured neurons. Science 274: 1921-1923
23. Goforth P. B., Ellis E. F. and Satin L. S. (1999) Enhancement of AMPA-mediated current after traumatic injury in cortical neurons. J. Neurosci. 19: 7367-7374
24. Lees K. R. (1998) Does neuroprotection improve stroke outcome? [see comments]. Lancet 351: 1447-1448
25. Ghosh A. and Greenberg M. E. (1995) Calcium signalling in neurons: Molecular mechanisms and cellular consequences. Science 268: 239-247
26. Bading H., Ginty D. D. and Greenberg M. E. (1993) Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 260: 181-186
27. Tymianski M., Charlton M. P., Carlen P. L. and Tator C. H. (1993) Source specificity of early calcium neurotoxicity in-cultured embryonic spinal neurons. J. Neurosci. 13: 2085-2104
28. Sattler R., Charlton M. P., Hafner M. and Tymianski M. (1998) Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 71: 2349-2364
29. Hollmann M. and Heinemann S. (1994) Cloned glutamate receptors. Ann. Rev. Neurosci. 17: 31-108
30. Laube B., Kuhse J. and Betz H. (1998) Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18: 2954-2961
31. Zukin R. S. and Bennett M. V. (1995) Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci. 18: 306-313
32. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M. et al. (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268: 2836-2843
33. Burnashev N., Schoepfer R., Monyer H., Ruppersberg J. P., Gunther N., Seeburg P. H. et al. (1992) Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science 257: 1415-1419
34. Schneggenburger R. and Ascher P (1997) Coupling of permeation and gating in an NMDA-channel pore mutant. Neuron 18: 167-177
35. Traynelis S. F., Burgess M. F., Zheng F., Lyuboslavsky P. and Powers J. L. (1998) Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J. Neurosci. 18: 6163-6175
36. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H. et al. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221
37. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K. et al. (1992) Molecular diversity of the NMDA receptor channel. Nature 358: 36-41
38. Forrest D., Yuzaki M., Soares H. D., Ng L., Luk D. C., Sheng M. et al. (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13: 325-338
39. Yuzaki M., Forrest D., Verselis L. M., Sun S. C., Curran T. and Connor J. A. (1996) Functional NMDA receptors are transiently active and support the survival of Purkinje cells in culture. J. Neurosci. 16: 4651-4661
40. Li Y., Erzurumlu R. S., Chen C., Jhaveri S. and Tonegawa S. (1994) Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76: 427-437
41. Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E. et al. (1995) Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 373: 151-155
42. Stern P., Behe P., Schoepfer R. and Colquhoun D. (1992) Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc. R. Soc. Lond. B Biol. Sci. 250: 271-277
43. 42a. Gallagher M. J., Huang H., Grant E. R. and Lynch D. R. (1997) The NR2B-specific interactions of polyamines and protons with the N-methyl-D-aspartate receptor. J. Biol. Chem. 272: 24971-24979
44. 42b. Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K. et al. (1992) Molecular diversity of the NMDA receptor channel. Nature 358: 36-41
45. 42c. Williams K., Russell S. L., Shen Y. M. and Molinoff P. B. (1993) Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10: 267-278
46. 42d. Kew J. N. C., Richards J. G., Mutel V. and Kemp J. A. (1998) Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J. Neurosci. 18: 1935-1943
47. Sheng M. and Pak D. T. (2000) Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu. Rev. Physiol. 62: 755-778
48. Standley S., Roche K. W., McCallum J., Sans N. and Wenthold R. J. (2000) PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28: 887-898
49. Okabe S., Miwa A. and Okado H. (1999) Alternative splicing of the C-terminal domain regulates cell surface expression of the NMDA receptor NR1 subunit. J. Neurosci. 19: 7781-7792
50. Logan S. M., Rivera F. E. and Leonard J. P. (1999) Protein kinase C modulation of recombinant NMDA receptor currents: roles for the C-terminal C1 exon and calcium ions. J. Neurosci. 19: 974-986
51. Ehlers M. D., Zhang S., Bernhardt J. P. and Huganir R. L. (1996) Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84: 745-755
52. Zhang S., Ehlers M. D., Bernhardt J. P., Su C. T. and Huganir R. L. (1998) Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron 21: 443-453
53. Kreutz M. R., Bockers T. M., Bockmann J., Seidenbecher C. I., Kracht B., Vorwerk C. K. et al. (1998) Axonal injury alters alternative splicing of the retinal NR1 receptor: the preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival. J. Neurosci. 18: 8278-8291
54. Halpain S., Hipolito A. and Saffer L. (1998) Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J. Neurosci. 18: 9835-9844
55. Jiang M., Lee C. L., Smith K. L. and Swann J. W. (1998) Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J. Neurosci. 18: 8356-8368
56. Jeffrey M., Goodsir C. M., Bruce M. E., McBride P. A. and Fraser J. R. (1997) In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol. Appl. Neurobiol. 23: 93-101
57. Garey L. J., Ong W. Y., Patel T. S., Kanani M., Davis A., Mortimer A. M. et al. (1998) Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia [see comments]. J. Neurol. Neurosurg. Psychiatr. 65: 446-453
58. Rao A. and Craig A. M. (1997) Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron 19: 801-812
59. Wyszynski M., Lin J., Rao A., Nigh E., Beggs A. H., Craig A. M. et al. (1997) Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature 385: 439-442
60. Matus A., Ackermann M., Pehling G., Byers H. R. and Fujiwara K. (1982) High actin concentrations in brain dendritic spines and postsynaptic densities. Proc. Natl. Acad. Sci. USA 79: 7590-7594
61. Kaech S., Fischer M., Doll T. and Matus A. (1997) Isoform specificity in the relationship of actin to dendritic spines. J. Neurosci. 17: 9565-9572.
62. Allison D. W., Gelfand V. I., Spector I. and Craig A. M. (1998) Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18: 2423-2436
63. 2+-dependent inactivation of NMDA receptors. J. Neurosci. 19: 1165-1178
64. Sattler R., Xiong Z., Lu W. Y., MacDonald J. F. and Tymianski M. (2000) Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J. Neurosci. 20: 22-33
65. Lin J. W., Wyszynski M., Madhavan R., Sealock R., Kim J. U. and Sheng M. (1998) Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J. Neurosci. 18: 2017-2027
66. Ehlers M. D., Fung E. T., O'Brien R. and Huganir R. L. (1998) Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J. Neurosci. 18: 720-730
67. Barish M. E. and Mansdorf N. B. (1991) Development of intracellular calcium responses to depolarization and to kainate and N-methyl-D-aspartate in cultured mouse hippocampal neurons. Brain Res. Dev. Brain Res. 63: 53-61
68. Marks J. D., Friedman J. E. and Haddad G. G. (1996) Vulnerability of CA1 neurons to glutamate is developmentally regulated. Brain Res. Dev. Brain Res. 97: 194-206
69. Wahl P., Schousboe A., Honore T. and Drejer J. (1989) Glutamate-induced increase in intracellular Ca2+ in cerebral cortex neurons is transient in immature cells but permanent in mature cells. J. Neurochem. 53: 1316-1319
70. Monyer H., Burnashev N., Laurie D. J., Sakmann B. and Seeburg P. H. (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540
71. Sheng M., Cummings J., Roldan L. A., Jan Y. N. and Jan L. Y. (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144-147
72. Wenzel A., Fritschy J. M., Mohler H. and Benke D. (1997) NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B and NR2C subunit proteins. J. Neurochem. 68: 469-478
73. Audinat E., Lambolez B., Rossier J. and Crepel F. (1994) Activity-dependent regulation of N-methyl-D-aspartate receptor subunit expression in rat cerebellar granule cells. Eur. J. Neurosci. 6: 1792-1800
74. Lindlbauer R., Mohrmann R., Hatt H. and Gottmann K. (1998) Regulation of kinetic and pharmacological properties of synaptic NMDA receptors depends on presynaptic exocytosis in rat hippocampal neurones. J. Physiol. 508 (Pt 2): 495-502
75. Bessho Y., Nawa H. and Nakanishi S. (1994) Selective up-regulation of an NMDA receptor subunit mRNA in cultured cerebellar granule cells by K(+)-induced depolarization and NMDA treatment. Neuron 12: 87-95
76. Gallo V, Suergiu R. and Levi G. (1987) Functional evaluation of glutamate receptor subtypes in cultured cerebellar neurones and astrocytes. Eur. J. Pharmacol. 138: 293-297
77. Balazs R., Jorgensen O. S. and Hack N. (1988) N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience 27: 437-451
78. Mizuta I., Katayama M., Watanabe M., Mishina M. and Ishii K. (1998) Developmental expression of NMDA receptor subunits and the emergence of glutamate neurotoxicity in primary cultures of murine cerebral cortical neurons. Cell. Mol. Life Sci. 54: 721-725
79. Cheng C., Fass D. M. and Reynolds I. J. (1999) Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels. Brain Res. 849: 97-108
80. Anegawa N. J., Lynch D. R., Verdoom T. A. and Pritchett D. B. (1995) Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death. J. Neurochem. 64: 2004-2012
81. Chazot P. L., Coleman S. K., Cik M. and Stephenson F. A. (1994) Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J. Biol. Chem. 269: 24403-24409
82. Morikawa E., Mori H., Kiyama Y., Mishina M., Asano T. and Kirino T. (1998) Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor. J. Neurosci. 18: 9727-9732
83. Kiyama Y., Manabe T., Sakimura K., Kawakami F., Mori H. and Mishina M. (1998) Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor epsilon 1 subunit. J. Neurosci. 18: 6704-6712
84. Kadotani H., Namura S., Katsuura G., Terashima T. and Kikuchi H. (1998) Attenuation of focal cerebral infarct in mice lacking NMDA receptor subunit NR2C. Neuroreport 9: 471-475
85. Sprengel R., Suchanek B., Amico C., Brusa R., Burnashev N., Rogov A. et al. (1998) Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92: 279-289
86. Mori H., Manabe T., Watanabe M., Satoh Y., Suzuki N., Toki S. et al. (1998) Role of the carboxy-terminal region of the GluR epsilon2 subunit in synaptic localization of the NMDA receptor channel. Neuron 21: 571-580
87. Steigerwald F., Schulz T. W., Schenker L. T., Kennedy M. B., Seeburg P. H., Kohr G. (2000) C-Terminal truncation of NR2 A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors. J. Neurosci. 20: 4573-4581
88. Garner C. C., Nash J. and Huganir R. L. (2000) PDZ domains in synapse assembly and signalling. Trends Cell Biol. 10: 274-280
89. Scannevin R. H. and Huganir R. L. (2000) Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. Neurosci. 1: 133-141
90. Lerea L. S. and McNamara J. O. (1993) Ionotropic glutamate receptor subtypes activate c-fos transcription by distinct calcium-requiring intracellular signalling pathways. Neuron 10: 31-41
91. Friedlander R. M., Gagliardini V., Hara H., Fink K. B., Li W., MacDonald G. et al. (1997) Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185: 933-940
92. Sheng M. (1997) Glutamate receptors put in their place. Nature 386: 221-223
93. Ponting C. P., Phillips C., Davies K. E. and Blake D. J. (1997) PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays 19: 469-479
94. Cho K. O., Hunt C. A. and Kennedy M. B. (1992) The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron 9: 929-942
95. Kistner U., Wenzel B. M., Veh R. W., Cases-Langhoff C., Garner A. M., Appeltauer U. et al. (1993) SAP90, a rat presynaptic protein related to the product of the Drosophila tumor suppressor gene dlg-A. J. Biol. Chem. 268: 4580-4583
96. Brenman J. E., Christopherson K. S., Craven S. E., McGee A. W. and Bredt D. S. (1996) Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J. Neurosci. 16: 7407-7415
97. Kim E. and Sheng M. (1996) Differential K+ channel clustering activity of PSD-95 and SAP97, two related membrane-associated putative guanylate kinases. Neuropharmacology 35: 993-1000
98. Muller B. M., Kistner U., Kindler S., Chung W. J., Kuhlendahl S., Fenster S. D. et al. (1996) SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17: 255-265
99. Muller B. M., Kistner U., Veh R. W., Cases-Langhoff C., Becker B., Gundelfinger E. D. et al. (1995) Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J. Neurosci. 15: 2354-2366
100. Kennedy M. B. (1995) Origin of PDZ (DHR, GLGF) domains [letter; comment]. Trends Biochem. Sci. 20: 350-350
101. Fanning A. S. and Anderson J. M. (1996) Protein-protein interactions: PDZ domain networks. Curr. Biol. 6: 1385-1388
102. Pawson T. (1995) Protein modules and signalling networks. Nature 373: 573-579
103. Ehlers M. D., Mammen A. L., Lau L. F. and Huganir R. L. (1996) Synaptic targeting of glutamate receptors. Curr. Opin. Cell Biol. 8: 484-489
104. Gomperts S. N. (1996) Clustering membrane proteins: It's all coming together with the PSD-95/SAP90 protein family. Cell 84: 659-662
105. Kornau H. C., Seeburg P. H. and Kennedy M. B. (1997) Interaction of ion channels and receptors with PDZ domain proteins. Curr. Opin. Neurobiol. 7: 368-373
106. Kornau H. C., Schenker L. T., Kennedy M. B. and Seeburg P. H. (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737-1740
107. Kim E., Niethammer M., Rothschild A., Jan Y. N. and Sheng M. (1995) Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature 378: 85-88
108. Doyle D. A., Lee A., Lewis J., Kim E., Sheng M. and MacKinnon R. (1996) Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. Cell 85: 1067-1076
109. Morais Cabral J. H., Petosa C., Sutcliffe M. J., Raza S., Byron O., Poy F. et al. (1996) Crystal structure of a PDZ domain. Nature 382: 649-652
110. Niethammer M., Kim E. and Sheng M. (1996) Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J. Neurosci. 16: 2157-2163
111. Brenman J. E., Chao D. S., Gee S. H., McGee A. W., Craven S. E., Santillano D. R. et al. (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84: 757-767
112. Stricker N. L., Christopherson K. S., Yi B. A., Schatz P. J., Raab R. W., Dawes G. et al. (1997) PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences. Nat. Biotechnol. 15: 336-342
113. Craven S. E. and Bredt D. S. (1998) PDZ proteins organize synaptic signaling pathways. Cell 93: 495-498
114. Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-685
115. Bredt D. S. and Snyder S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86: 9030-9033
116. Garthwaite J., Charles S. L. and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as inter-cellular messenger in the brain. Nature 336: 385-388
117. Sattler R., Xiong Z., Lu W. Y., Hafner M., MacDonald J. F., Tymianski M. (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284: 1845-1848
118. Schwarze S. R. and Dowdy S. F. (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21: 45-48
119. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J. W. et al. (2002) Treatment of ischemic brain damage by perturbing NMDA rece. Science 298: 846-850
120. Schinder A. F., Olson E. C., Spitzer N. C. and Montal M. (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16: 6125-6133
121. Atlante A, Calissano P, Bobba A, Giannattasio S, Marra E, Passarella S. (2001) Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497: 1-5
122. Akerman K. E. (1978) Changes in membrane potential during calcium ion influx and efflux across the mitochondrial membrane. Biochim. Biophys. Acta 502: 359-366
123. Gunter T. E. and Pfeiffer D. R. (1990) Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258: C755-C786
124. Loew L. M., Carrington W., Tuft R. A. and Fay F. S. (1994) Physiological cytosolic Ca2+ transients evoke concurrent mitochondrial depolarizations. Proc. Natl. Acad. Sci. USA 91: 12579-12583
125. Bauer M. K., Vogt M., Los M., Siegel J., Wesselborg S. and Schulze-Osthoff K. (1998) Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273: 8048-8055
126. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281: 1309-1312
127. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I. et al. (1997) Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372
128. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T. et al. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182: 367-377
129. Kumar C., Okuda M., Ikai I. and Chance B. (1990) Luminol enhanced chemiluminescence of the perfused rat heart during ischemia and reperfusion. FEBS Lett. 272: 121-124
130. Sussman M. S. and Bulkley G. B. (1990) Oxygen-derived free radicals in reperfusion injury. Methods Enzymol. 186: 711-723
131. Juurlink B. H. (1997) Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci. Biobehav. Rev. 21: 151-166
132. Chanock S. J., el Benna J., Smith R. M. and Babior B. M. (1994) The respiratory burst oxidase. J. Biol. Chem. 269: 24519-24522
133. Shami P. J., Sauls D. L. and Weinberg J. B. (1998) Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide. Leukemia 12: 1461-1466
134. Sattler R., Xiong Z., Lu W. Y., Hafner M., MacDonald J. F. and Tymianski M. (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284: 1845-1848
135. Koppenol W. H., Moreno J. J., Pryor W. A., Ischiropoulos H. and Beckman J. S. (1992) Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5: 834-842
136. Beckman J. S., Ischiropoulos H., Zhu L., van der Woerd M., Smith C., Chen J. et al. (1992) Kinetics of superoxide dismu. Arch. Biochem. Biophys. 298: 438-445
137. Radi R., Beckman J. S., Bush K. M. and Freeman B. A. (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487
138. Darley-Usmar V. M., Hogg N., O'Leary V. J., Wilson M. T. and Moncada S. (1992) The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 17: 9-20
139. Moreno J. J. and Pryor W. A. (1992) Inactivation of alpha 1-proteinase inhibitor by peroxynitrite. Chem. Res. Toxicol. 5: 425-431
140. Buki A., Okonkwo D. O., Wang K. K. and Povlishock J. T. (2000) Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20: 2825-2834
141. Graham S. H. and Chen J. (2001) Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21: 99-109
142. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M. and Schreiber S. S. (1997) Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment. Exp. Neurol. 145: 81-88
143. Liu X., Kim C. N., Yang J., Jemmerson R. and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157
144. Wang X. (2001) The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933
145. Zou H., Li Y., Liu X. and Wang X. (1999) An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274: 11549-11556
146. Rodriguez J. and Lazebnik Y. (1999) Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13: 3179-3184
147. Sabol S. L., Li R., Lee T. Y. and Abdul-Khalek R. (1998) Inhibition of apoptosis-associated DNA fragmentation activity in nonapoptotic cells: the role of DNA fragmentation factor-45 (DFF45/ICAD). Biochem. Biophys. Res. Commun. 253: 151-158
148. Sakahira H., Enari M. and Nagata S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99
149. Woo M., Hakem R., Soengas M. S., Duncan G. S., Shahinian A., Kagi D. et al. (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12: 806-819
150. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A. and Nagata S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50
151. Raghupathi R., Graham D. I. and McIntosh T. K. (2000) Apoptosis after traumatic brain injury. J. Neurotrauma 17: 927-938
152. Hengartner M. O. (2000) The biochemistry of apoptosis. Nature 407: 770-776
153. Xiang H., Kinoshita Y., Knudson C. M., Korsmeyer S. J., Schwartzkroin P. A., Morrison R. S. (1998) Bax involvement in p53-mediated neuronal cell death. J. Neurosci. 18: 1363-1373
154. Banasiak K. J. and Haddad G. G. (1998) Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797: 295-304
155. McGahan L., Hakim A. M. and Robertson G. S. (1998) Hippocampal Myc and p53 expression following transient global ischemia. Brain Res. Mol. Brain Res. 56: 133-145
156. Lu J., Moochhala S., Kaur C. and Ling E. (2000) Changes in apoptosis-related protein (p53, Bax, Bcl-2 and Fos) expression with DNA fragmentation in the central nervous system in rats after closed head injury. Neurosci. Lett. 290: 89-92
157. Napieralski J. A., Raghupathi R. and McIntosh T. K. (1999) The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res. Mol. Brain Res. 71: 78-86
158. Cote J. and Ruiz-Carrillo A. (1993) Primers for mitochondrial DNA replication generated by endonuclease G. Science 261: 765-769
159. Liu X., Zou H., Slaughter C. and Wang X. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184
160. Liu X., Li P., Widlak P., Zou H., Luo X., Garrard W. T. et al. (1998) The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. USA 95: 8461-8466
161. Li L. Y., Luo X. and Wang X. (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412: 95-99
162. Joza N., Susin S. A., Daugas E., Stanford W. L., Cho S. K., Li C. Y. et al. (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554
163. Zhang X., Chen J., Graham S. H., Du L., Kochanek P. M., Draviam R. et al. (2002) Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82: 181-191